Apples entire business model goes against that philosophy. Reoccurring revenue is where it’s at. Unless you actually want to make things better, in which case you’re shouldn’t be in business. (Which these guys blessedly aren’t!)
It’s not but it is also a) a selected example of many to illustrate a point with clarity, b) a widely emulated model, c) essentially what the company who pivoted pivoted towards. Rather than a one time solution, a reoccurring subscription model, so is salient and likely it or a similar model was considered in that switch.
I agree. Sadly most investors risking capital don’t. That’s why I love these guys and hope they get their funding. I imagine they fall outside some kickstarted T&C prohibiting bioengineering for use in humans, and likely Patreon too, but I would definitely kick over some bucks to help them if there were a channel.
